Clinical Trials Logo

Ventricular Premature Complexes clinical trials

View clinical trials related to Ventricular Premature Complexes.

Filter by:

NCT ID: NCT02666742 Completed - Stroke Clinical Trials

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

STROKE-VT
Start date: February 16, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to learn if taking a drug called direct oral anticoagulant after an ablation procedure keeps blood clots from forming and lowers the chance of having a stroke in patients with ventricular tachycardia or arrhythmia (VT).

NCT ID: NCT02360397 Completed - Myocardial Ischemia Clinical Trials

Ranolazine Mediated PVC Reduction in Ischemic Heart Disease

Start date: December 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether ranolazine has beneficial effects on cardiac ischemia through reduction of premature ventricular contraction burden.

NCT ID: NCT02279030 Completed - Clinical trials for Premature Ventricular Contractions

Use of MIBG Scan Images in PVC Ablations

PVC-MIBG
Start date: June 2015
Phase:
Study type: Observational

The purpose of this study is to assess if Single Photon Emission Computed Tomography (SPECT) demonstrating cardiac innervation can be integrated into current electrophysiology voltage mapping system and provide improved guidance for ablation of PVCs.

NCT ID: NCT02155907 Completed - Stroke Clinical Trials

Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA

Start date: June 1, 2013
Phase:
Study type: Observational [Patient Registry]

Purpose 1. To validate 2 -day loop recording ( R.Test Evolution 4 ) to 2 -day Holter recording (gold standard) for the detection of atrial fibrillation of ≥ 30 seconds duration in a consecutive population of patients with stroke or transient ischemic attack (TIA). 2. To determine whether short run of atrial fibrillation (< 30s ) or the presence of many supraventricular extrasystoles detected on Holter recording, is associated with risk of re-stroke in a consecutive population of patients with stroke or TIA . 3. To test whether a 7-day Loop Recording (R -test) detects more patients with atrial fibrillation than 2 days of Holter recording in a consecutive population of patients with stroke or TIA.